Evidence map›Paper›PMID 35059810›Full record

ArticleInternational journal of legal medicine2022

Creation of a Forensic Pathology Biobank in Switzerland: which issues and research opportunities?

K Wiskott, F Gilardi, K Michaud, M Augsburger, C Castiglioni, A Carminati, S Grabherr, A Thomas, T Fracasso

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

K WiskottForensic Medicine Unit, University Center of Legal Medicine, Rue Michel-Servet 1, 1205, Geneva, Switzerland. kim.wiskott@hcuge.ch.
F GilardiFaculty Unit of Toxicology, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
K MichaudForensic Medicine Unit, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
M AugsburgerForensic Toxicology and Chemistry Unit, University Center of Legal Medicine, Rue Michel-Servet 1, 1205, Geneva, Switzerland.
C CastiglioniForensic Medicine Unit, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
A CarminatiForensic Medicine Unit, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
S GrabherrDirection, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
A ThomasFaculty Unit of Toxicology, University Center of Legal Medicine, Chemin de la Vulliette 4, 1000, Lausanne 25, Switzerland.
T FracassoForensic Medicine Unit, University Center of Legal Medicine, Rue Michel-Servet 1, 1205, Geneva, Switzerland.
University Centre of Legal Medicine · CH

Funding

Swiss National Science Foundation 31003A-182420
6 · The paper itself

Abstract

A biobank is a collection of biological material associated with health database. The field of biobanking has significantly developed over the past 30 years. Research based on biobank material gives access to data of a large number of people and can often significantly accelerate the understanding of disease and improve the quality of care. In the University Center of Legal Medicine Lausanne-Geneva, samples collected during autopsies are used for forensic investigations. The legal and ethical framework to use these samples for research is often complex and confused, which is unfortunate given the potential of these biospecimens. Indeed, forensic samples are valuable for research because they originate in part from young (including pediatrics cases) and healthy people who are poorly represented in worldwide institutional biobanks. In this context at the beginning of the year 2019, the Forensic Pathology Biobank was created. Creation of a forensic pathology biobank is the best way to standardize local conservation practices and improve personal data management, thus providing a very valuable biological material for scientific projects. Its development gives rise to many questions about technical standards, ethical and legal issues but also many research opportunities.

Indexed as

Biological Specimen BanksChildForensic PathologyHumansSwitzerlandBiobankData managementEthicsForensicResearch

Identifiers

PMID35059810
OpenAlexW4205913974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.